Anika Therapeutics Reports 52% Total Revenue Growth in Second Quarter 2010

BEDFORD, Mass.--(BUSINESS WIRE)--Anika Therapeutics, Inc. (Nasdaq: ANIK), a leader in products for tissue protection, healing, and repair, based on hyaluronic acid (“HA”) technology, today reported financial results for the quarter ended June 30, 2010.

MORE ON THIS TOPIC